KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
73 hedge funds and large institutions have $905M invested in Kinnate Biopharma Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
73
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$17M | |
| 2 | +$14.6M | |
| 3 | +$13.1M | |
| 4 |
Morgan Stanley
New York
|
+$6.88M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$4.32M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$10.4M | |
| 3 | -$10.4M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$4.47M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.19M |